0

Blood Plasma Derivative Market Expected to Reach $89.767 Billion by 2030

 
2022
Blood Plasma Derivative Market

Report Code : A00534

quote Alarming rise in prevalence of immunodeficiency disorder, advancements in technology in pharmaceutical, increase in number of key players for manufacturing of blood plasma derivative products, surge in demand for immunoglobulin product, and growth in number of approvals for blood plasma derivatives are expected to notably contribute toward the growth of the global blood plasma derivative market during the forecast period. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Blood Plasma Derivatives Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global blood plasma derivatives market size was valued at $36.471 billion in 2020, and is estimated to reach $89.767 billion by 2030, growing at a CAGR of 9.4% from 2021 to 2030.

Blood plasma is clear liquid component of blood in which red blood cells, white blood cells, and platelets are suspended. It plays a vital role in maintaining proper pH balance in the body and transporting nutrients throughout the body. It is composed of more than 100 different proteins, including albumin, fibrinogen, immunoglobulins, protease inhibitors, and clotting factors. Plasma derivatives are products that are derived from blood plasma on fractionation, and are widely used to treat variety of diseases. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.

The factors that drive the growth of the blood plasma derivatives market include increase in prevalence of life-threatening diseases such as immunodeficiency diseases & hemophilia, rise in awareness toward blood & plasma donation, and growth in adoption of blood plasma derivatives products.

Moreover, other factors that are responsible for the growth of the plasma derived derivatives are increase in awareness of blood & plasma donation, rise in geriatric population, & higher adoption of the blood plasma derivative products. Furthermore, market players are focused on manufacturing of different blood plasma derivatives product. For instance, in April 2020, Biotest, a pharmaceutical company, announced the launch of a life saving medicine, which is derived blood plasma of COVID-19 patient. Moreover, surge in prevalence of geriatric population, who are more vulnerable to chronic disease escalate the blood plasma derivatives market growth.

In addition, rise in disposable income and development of the pharmaceutical sector for manufacturing of plasma derived products is anticipated to drive growth of the market. In addition, expansion of many clinical studies on various types of products to evaluate their safety and efficacy propels the growth of the market. For instance, in February 2022, the U.S Food and Drug Administration (FDA), announced clinical research activities in order to enhance the safety of blood plasma derive product, such as protein used to treat immune system disorder and clotting disorder.

Rise in number of approval for plasma derived products and increase in number of pharmaceutical manufacturing companies are the key factors that further boost growth of the blood plasma derivatives market. However, high cost of plasma derivative-based treatment and risk of side effects associated after using plasma derivatives impede the market growth. Conversely, the development of superior methods for preservation of plasma derivatives along with advanced processes for fractionation and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.

The blood plasma derivatives market is segmented into type, application, end user, and region. On the basis of type, the market is segregated into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulin segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to rise in R&D activities related to manufacturing of plasma derived products in the pharmaceutical sector and increase in prevalence of immune disease.

Depending on application, the blood plasma derivatives market is classified into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's Disease (vWD), and other applications. The immunodeficiency diseases segment is expected to lead during the forecast period, owing to increase in prevalence of immune diseases and development of advanced drugs by the pharmaceutical industry. By end user, the market is categorized into hospital, clinic, and other end users. The hospital segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to surge in number of hospital, and initiatives taken by governments & private organizations to develop healthcare sector.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global plasma derivatives market. The COVID-19 pandemic has stressed healthcare systems in the world. Meanwhile, in August 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for convalescent plasma for the treatment of hospitalized patients with COVID-19. The antibodies or plasma are collected from donors who have recovered from COVID-19. It may contain antibodies to SARS-CoV-2, which help suppress viral replication. Thus, upsurge in demand for plasma derived product for the treatment of infectious diseases positively impacted the growth of the market.

Key Findings Of The Study

  • By type, the immunodeficiency disorder was the highest contributor to the blood plasma derivatives market in 2020.
  • On the basis of application, other application dominated the market in 2020, and is expected to continue this trend during the forecast period.
  • Depending on end user, the hospital segment led the blood plasma derivatives market in 2020.
  • Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

North America garnered a major share of the blood plasma derivatives market in 2020, and is expected to continue to dominate during the forecast period, owing to increase in number of approval for blood plasma derivative product and rise in number of key players to manufacture plasma derived drug. However, Asia-Pacific is expected to register highest CAGR of 11.0% from 2021 to 2030, owing to increase in prevalence of immune disease, rise in awareness toward plasma derivatives, and surge in healthcare expenditure.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Feb 2024

Solid State Relay Market

Download Sample
rep-img

Published Date Feb 2024

Alternators Market

Download Sample

Buy Full Version
"Blood Plasma Derivative Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers